Genetic Markers of Mediastinal Tumors

Morgenthaler, 1993, Thymoma, Mayo Clin Proc, 68, 1110, 10.1016/S0025-6196(12)60907-0 Detterbeck, 2006, Clinical value of the WHO classification system of thymoma, Ann Thorac Surg, 81, 2328, 10.1016/j.athoracsur.2005.11.067 Zettl, 2000, Recurrent genetic aberrations in thymoma and thymic carcinoma, Am J Pathol, 157, 257 Knuutila, 1998, DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies, Am J Pathol, 152, 1107 Lin, 1999, Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions, Eur J Cancer, 35, 1730, 10.1016/S0959-8049(99)00205-1 Vincent, 1999, The role of T-cells in the initiation of autoantibody responses in thymoma patients, Pathol Res Pract, 195, 535, 10.1016/S0344-0338(99)80002-8 Utada, 2000, Mapping of target regions of allelic loss in primary breast cancers to 1-cM intervals on genomic contigs at 6q21 and 6q25.3, Jpn J Cancer Res, 91, 293, 10.1111/j.1349-7006.2000.tb00944.x Honchel, 1996, Tumor necrosis factor-alpha allelic frequency and chromosome 6 allelic imbalance in patients with colorectal cancer, Cancer Res, 56, 145 Yeung, 1993, The retinoblastoma-related gene, RB2, maps to human chromosome 16q12 and rat chromosome 19, Oncogene, 8, 3465 Berx, 1995, E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers, EMBO J, 14, 6107, 10.1002/j.1460-2075.1995.tb00301.x Zhou, 2001, Thymic epithelial tumors can develop along two different pathogenetic pathways, Am J Pathol, 159, 1853, 10.1016/S0002-9440(10)63031-3 Inoue, 2003, Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas, Cancer Res, 63, 3708 Shino, 1995, Clinicopathologic evaluation of immunohistochemical E-cadherin expression in human gastric carcinomas, Cancer, 76, 2193, 10.1002/1097-0142(19951201)76:11<2193::AID-CNCR2820761104>3.0.CO;2-2 Sulzer, 1998, Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in nonsmall cell lung cancer, Am J Respir Crit Care Med, 157, 1319, 10.1164/ajrccm.157.4.9703099 Tamura, 1996, Decreased E-cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the oesophagus, Br J Surg, 83, 1608 Lee, 2007, Genome-wide genetic aberrations of thymoma using cDNA microarray-based comparative genomic hybridization, BMC Genomics, 8, 305, 10.1186/1471-2164-8-305 Toretsky, 2003, Translocation (11;15;19): a highly specific chromosome rearrangement associated with poorly differentiated thymic carcinoma in young patients, Am J Clin Oncol, 26, 300, 10.1097/01.COC.0000020960.98562.84 Jain, 1984, The treatment of extragonadal seminoma, J Clin Oncol, 2, 820, 10.1200/JCO.1984.2.7.820 Przygodzki, 1996, Primary mediastinal and testicular seminomas: a comparison of K-ras-2 gene sequence and p53 immunoperoxidase analysis of 26 cases, Hum Pathol, 27, 975, 10.1016/S0046-8177(96)90227-0 Suster, 1998, Germ cell tumors of the mediastinum and testis: a comparative immunohistochemical study of 120 cases, Hum Pathol, 29, 737, 10.1016/S0046-8177(98)90284-2 Sung, 2008, Primary mediastinal seminoma: a comprehensive assessment integrated with histology, immunohistochemistry, and fluorescence in situ hybridization for chromosome 12p abnormalities in 23 cases, Am J Surg Pathol, 32, 146, 10.1097/PAS.0b013e3181379edf Hiroshima, 2001, Apoptosis and proliferative activity in mature and immature teratomas of the mediastinum, Cancer, 92, 1798, 10.1002/1097-0142(20011001)92:7<1798::AID-CNCR1696>3.0.CO;2-V Giuliano, 2005, Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity, Biochim Biophys Acta, 1731, 48, 10.1016/j.bbaexp.2005.08.006 Looijenga, 1999, Pathogenesis of testicular germ cell tumours, Rev Reprod, 4, 90, 10.1530/ror.0.0040090 Bosl, 1994, Clinical relevance of the i(12p) marker chromosome in germ cell tumors, J Natl Cancer Inst, 86, 349, 10.1093/jnci/86.5.349 Copie-Bergman, 2002, MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas, Mod Pathol, 15, 1172, 10.1097/01.MP.0000032534.81894.B3 Lazzarino, 1997, Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients, J Clin Oncol, 15, 1646, 10.1200/JCO.1997.15.4.1646 Capello, 2000, Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia, Blood, 95, 651 Tsang, 1996, Molecular characterization of primary mediastinal B cell lymphoma, Am J Pathol, 148, 2017 Wessendorf, 2007, Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH), Leukemia, 21, 2463, 10.1038/sj.leu.2404919 Feuerhake, 2005, NFkappaB activity, function, and target gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes, Blood, 106, 1392, 10.1182/blood-2004-12-4901 Roberts, 2006, Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival, Blood, 108, 311, 10.1182/blood-2005-11-4742 Melzner, 2005, Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line, Blood, 105, 2535, 10.1182/blood-2004-09-3701 Kuppers, 2002, Molecular biology of Hodgkin's lymphoma, Adv Cancer Res, 84, 277, 10.1016/S0065-230X(02)84009-X Joos, 2003, Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2, Int J Cancer, 103, 489, 10.1002/ijc.10845 Izban, 2001, Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells, Mod Pathol, 14, 297, 10.1038/modpathol.3880306 Ferner, 2002, International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis, Cancer Res, 62, 1573 Strollo, 1997, Primary mediastinal tumors: part II. Tumors of the middle and posterior mediastinum, Chest, 112, 1344, 10.1378/chest.112.5.1344 Ozer, 2007, Association of MYCN amplification and 1p deletion in neuroblastomas with high tumor vascularity, Appl Immunohistochem Mol Morphol, 15, 181, 10.1097/01.pai.0000210418.38246.58 Scaruffi, 2004, Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization, Mol Diagn, 8, 93, 10.2165/00066982-200408020-00003 White, 2005, Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma, Oncogene, 24, 2684, 10.1038/sj.onc.1208306 Munoz, 2006, Determination of genomic damage in neuroblastic tumors by arbitrarily primed PCR: MYCN amplification as a marker for genomic instability in neuroblastomas, Neuropathology, 26, 165, 10.1111/j.1440-1789.2006.00675.x Vargas, 1997, Loss of heterozygosity on the short arm of chromosomes 1 and 3 in sporadic pheochromocytoma and extra-adrenal paraganglioma, Hum Pathol, 28, 411, 10.1016/S0046-8177(97)90028-9 Heutink, 1992, A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter, Hum Mol Genet, 1, 7, 10.1093/hmg/1.1.7 Lemeta, 2006, Frequent loss of heterozygosity at 6q in pheochromocytoma, Hum Pathol, 37, 749, 10.1016/j.humpath.2006.02.002 Gimenez-Roqueplo, 2008, Recent advances in the genetics of phaeochromocytoma and functional paraganglioma, Clin Exp Pharmacol Physiol, 35, 376, 10.1111/j.1440-1681.2008.04881.x Gimenez-Roqueplo, 2001, The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway, Am J Hum Genet, 69, 1186, 10.1086/324413